I think you underestimate the rigour of the medical community and its insistence that only the highest quality testing is offered. In places like Australia, private pathology labs will be able to easily keep up with antibody testing for a vaccine rolled out gradually on the basis of need - most at-risk populations first - over at least a year. They will have a financial incentive to do so too! It will be interesting to see how it plays out.
AT1 FY21 - General Discussion + FA, page-385
-
- There are more pages in this discussion • 2,049 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 497908 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 67200 | 3 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable